Your browser doesn't support javascript.
loading
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
Reis, Henning; van der Vos, Kristan E; Niedworok, Christian; Herold, Thomas; Módos, Orsolya; Szendroi, Attila; Hager, Thomas; Ingenwerth, Marc; Vis, Daniël J; Behrendt, Mark A; de Jong, Jeroen; van der Heijden, Michiel S; Peyronnet, Benoit; Mathieu, Romain; Wiesweg, Marcel; Ablat, Jason; Okon, Krzysztof; Tolkach, Yuri; Keresztes, David; Nagy, Nikolett; Bremmer, Felix; Gaisa, Nadine T; Chlosta, Piotr; Kriegsmann, Joerg; Kovalszky, Ilona; Timar, József; Kristiansen, Glen; Radzun, Heinz-Joachim; Knüchel, Ruth; Schuler, Martin; Black, Peter C; Rübben, Herbert; Hadaschik, Boris A; Schmid, Kurt Werner; van Rhijn, Bas W G; Nyirády, Péter; Szarvas, Tibor.
Afiliação
  • Reis H; Institute of Pathology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.
  • van der Vos KE; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
  • Niedworok C; Division of Molecular Carcinogenesis, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
  • Herold T; Department of Urology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.
  • Módos O; Institute of Pathology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.
  • Szendroi A; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
  • Hager T; Department of Urology, Semmelweis University, Budapest, Hungary.
  • Ingenwerth M; Department of Urology, Semmelweis University, Budapest, Hungary.
  • Vis DJ; Institute of Pathology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.
  • Behrendt MA; Institute of Pathology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.
  • de Jong J; Division of Molecular Carcinogenesis, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
  • van der Heijden MS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
  • Peyronnet B; Department of Surgery, Division of Urology, University Hospital of Basel, Basel, Switzerland.
  • Mathieu R; Department of Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
  • Wiesweg M; Division of Molecular Carcinogenesis, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
  • Ablat J; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
  • Okon K; Department of Urology, University of Rennes, Rennes, France.
  • Tolkach Y; Department of Urology, University of Rennes, Rennes, France.
  • Keresztes D; Department of Medical Oncology, West German Cancer Center, University of Duisburg Essen, University Hospital Essen, Essen, Germany.
  • Nagy N; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Bremmer F; Department of Pathomorphology, Jagiellonian University, Cracow, Poland.
  • Gaisa NT; Institute of Pathology, University of Bonn, Bonn, Germany.
  • Chlosta P; Department of Urology, Semmelweis University, Budapest, Hungary.
  • Kriegsmann J; Department of Urology, Semmelweis University, Budapest, Hungary.
  • Kovalszky I; Institute of Pathology, University of Göttingen, Göttingen, Germany.
  • Timar J; Institute of Pathology, RWTH Aachen University, Aachen, Germany.
  • Kristiansen G; Department of Pathomorphology, Jagiellonian University, Cracow, Poland.
  • Radzun HJ; Center for Histology, Cytology and Molecular Diagnostics Trier, Trier, Germany.
  • Knüchel R; First Institute of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Schuler M; Second Department of Pathology, Semmelweis University, Budapest, Hungary.
  • Black PC; Institute of Pathology, University of Bonn, Bonn, Germany.
  • Rübben H; Institute of Pathology, University of Göttingen, Göttingen, Germany.
  • Hadaschik BA; Institute of Pathology, RWTH Aachen University, Aachen, Germany.
  • Schmid KW; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
  • van Rhijn BWG; Department of Medical Oncology, West German Cancer Center, University of Duisburg Essen, University Hospital Essen, Essen, Germany.
  • Nyirády P; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Szarvas T; Department of Urology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.
Int J Cancer ; 143(7): 1764-1773, 2018 10 01.
Article em En | MEDLINE | ID: mdl-29672836
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Adenocarcinoma / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Instabilidade de Microssatélites Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Adenocarcinoma / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Instabilidade de Microssatélites Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article